2009, Number 1
<< Back Next >>
Acta Med 2009; 7 (1)
Systemic hypertension. Current concepts
Jáuregui AR
Language: Spanish
References: 15
Page: 17-23
PDF size: 80.11 Kb.
ABSTRACT
No abstract
REFERENCES
Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The seventh report of the Joint National Committee (JNC 7). Hypertension 2003; 42: 1206.
Jáuregui R. Clasificación de la hipertensión arterial sistémica. Rev Endocr y Nutr 1993; 1: 86.
Chalmers J. WHO-ISH Hypertension Guidelines Committee. Guidelines for the management of Hypertension. J Hypertens 1999; 17: 151.
Consejo Nacional de Población. Esperanza de vida al nacimiento 1980-2000. México: CONAPO; 1992: 16-25.
4a. Velásquez O: Hipertensión arterial en México: Resultados de la Encuesta Nacional de Salud (ENSA 2000). Arch Cardiol Mex 2002; 72: 71.
Ruesga E, Jáuregui R, Chiú G. Texto de Cardiología. México, D.F: Editorial Manual Moderno; 2005: 635-642.
Olshansky SJ, Passaro DJ, Hershow RC et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005; 352: 1138.
Guidelines for the management of arterial hypertension. Committee for practice guidelines to improve the quality of clinical practice and patient care in Europe. Eur Heart J 2007; 28(12): 1462.
Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet 2007; 370: 591-603.
Saha S, Molnar J, Arora R. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials. Dia Obes Met 2008; 10: 41.
Volpe M. Microalbuminuria screening in patients with hypertension: recommendations for clinical practice. Int J Clin Pract 2008; 62(1): 97.
Kunz R, Friedrich Ch et al. Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease. Ann Intern Med 2008; 148(1): 30.
Matchar D, McCrory D et al. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann Intern Med 2008; 148(1): 16.
Kaplan N, Izzo J. Refractory hypertension en Hypertension Primer. Philadelphia: Lippincott; 2003: 382-384.
Vadnajathan S. Clinical pharmacokinetics and pharmacodynamics of aliskiren. Clin Pharm 2008; 47: 515-531.
Full text